The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Syros Pharmaceuticals Inc (NASDAQ: SYRS) closed the day trading at $0.23 down -10.25% from the previous closing price of $0.26. In other words, the price has decreased by -$10.25 from its previous closing price. On the day, 2.68 million shares were traded. SYRS stock price reached its highest trading level at $0.2679 during the session, while it also had its lowest trading level at $0.2311.
Ratios:
For a better understanding of SYRS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.25 and its Current Ratio is at 2.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 04, 2020, Upgraded its rating to Buy and sets its target price to $15 from $11 previously.
On September 22, 2020, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’24 when AKKARAJU SRINIVAS bought 9,333 shares for $0.25 per share.
Flagship Pioneering Fund VII, bought 1,331,624 shares of SYRS for $279,641 on Dec 27 ’24. On Dec 13 ’24, another insider, Flagship VentureLabs IV LLC, who serves as the Affiliate of the company, bought 21,333 shares for $0.23 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRS now has a Market Capitalization of 6297587 and an Enterprise Value of 8248577. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.16. Its current Enterprise Value per Revenue stands at 21.369 whereas that against EBITDA is -0.075.
Stock Price History:
Over the past 52 weeks, SYRS has reached a high of $7.98, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is -71.70%, while the 200-Day Moving Average is calculated to be -92.98%.
Shares Statistics:
Over the past 3-months, SYRS traded about 9.24M shares per day on average, while over the past 10 days, SYRS traded about 4668420 shares per day. A total of 26.83M shares are outstanding, with a floating share count of 17.43M. Insiders hold about 35.03% of the company’s shares, while institutions hold 36.36% stake in the company. Shares short for SYRS as of 1734048000 were 1565323 with a Short Ratio of 0.17, compared to 1731628800 on 4773354. Therefore, it implies a Short% of Shares Outstanding of 1565323 and a Short% of Float of 6.35.
